Anifera awarded seed funding for research from UK’s Centre for Innovation Excellence in Livestock (CIEL)

· Funding will enable Anifera to investigate efficacy of their leading compound to enhance antibiotic treatment for bovine mastitis, a significant economic and welfare challenge for the global dairy industry · Data will support development of a commercialisation plan for their leading compound, globally, with the goal of improving efficacy of older antibiotics and ultimately reducing overall antibiotic usage in livestockLondon, UK, 14 September 2021 – Anifera, a company focused on developing adjunct therapy to improve the efficacy of antibiotics used in animal health, today announced